Christopher S. Boerner
Chief Executive Officer at Bristol-Myers Squibb Company
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 2 boards, counting each seat separately. Longest: Bristol-Myers Squibb Company, 2 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 11, 2026 | Colgate-Palmolive Company | Grant or award | +1,383 | โ | โ |
| Mar 10, 2026 | Bristol-Myers Squibb Company | Option exercise | +6,618 | โ | โ |
| Mar 10, 2026 | Bristol-Myers Squibb Company | Other | โ743 | โ | โ |
| Mar 10, 2026 | Bristol-Myers Squibb Company | Shares withheld for tax | โ3,006 | $60.13 | $180,751 |
| Mar 10, 2026 | Bristol-Myers Squibb Company | Option exercise | +6,733 | โ | โ |
| Mar 10, 2026 | Bristol-Myers Squibb Company | Other | โ727 | โ | โ |
| Mar 10, 2026 | Bristol-Myers Squibb Company | Shares withheld for tax | โ3,073 | $60.13 | $184,779 |
| Mar 10, 2026 | Bristol-Myers Squibb Company | Option exercise | +40,398 | โ | โ |
| Mar 10, 2026 | Bristol-Myers Squibb Company | Other | โ19,835 | โ | โ |
| Mar 10, 2026 | Bristol-Myers Squibb Company | Shares withheld for tax | โ10,518 | $60.13 | $632,447 |
| Mar 10, 2026 | Bristol-Myers Squibb Company | Option exercise | +17,788 | โ | โ |
| Mar 10, 2026 | Bristol-Myers Squibb Company | Other | โ8,734 | โ | โ |
| Mar 10, 2026 | Bristol-Myers Squibb Company | Shares withheld for tax | โ4,632 | $60.13 | $278,522 |
| Nov 1, 2025 | Bristol-Myers Squibb Company | Option exercise | +2,964 | โ | โ |
| Nov 1, 2025 | Bristol-Myers Squibb Company | Other | โ544 | โ | โ |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.